Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands

被引:65
作者
van Rijn, Anne F. [2 ]
Fockens, Paul [2 ]
Siersema, Peter D. [1 ]
Oldenburg, Bas [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, NL-3584 CX Utrecht, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol Hepatol, NL-1105 AZ Amsterdam, Netherlands
关键词
Colorectal cancer; Crohn's disease; Dysplasia; Guidelines; Surveillance; Ulcerative colitis; CANCER; DISEASE; RISK; UPDATE;
D O I
10.3748/wjg.15.226
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To study adherence to the widely accepted surveillance guidelines for patients with long-standing colitis in the Netherlands. METHODS: A questionnaire was sent to all 244 gastroenterologists in the Netherlands. RESULTS: The response rate was 63%. Of all gastroenterologists, 95% performed endoscopic surveillance in ulcerative colitis (UC) patients and 65% in patients with Crohn's colitis. The American Gastroenterological Association (AGA) guidelines were followed by 27%, while 27% and 46% followed their local hospital protocol or no specific protocol, respectively. The surveillance was correctly initiated in cases of pancolitis by 53%, and in cases of left-sided colitis by 44% of the gastroenterologists. Although guidelines recommend 4 biopsies every 10 cm, less than 30 biopsies per colonoscopy were taken by 73% of the responders. Only 31%, 68% and 58% of the gastroenterologists referred patients for colectomy when low-grade dysplasia, high-grade dysplasia (HGD) or Dysplasia Associated Lesion or Mass (DALM) was present, respectively. CONCLUSION: Most Dutch gastroenterologists perform endoscopic surveillance without following international recommended guidelines. This practice potentially leads to a decreased sensitivity for dysplasia, rendering screening for colorectal cancer in this population highly ineffective. (c) 2009 The WJG Press and Baishideng. All rights reserved.
引用
收藏
页码:226 / 230
页数:5
相关论文
共 14 条
[1]  
BERNSTEIN CN, 1995, AM J GASTROENTEROL, V90, P2106
[2]  
Cummings SM, 2001, HEALTH SERV RES, V35, P1347
[3]   Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis [J].
Eaden, J ;
Abrams, K ;
McKay, H ;
Denley, H ;
Mayberry, J .
JOURNAL OF PATHOLOGY, 2001, 194 (02) :152-157
[4]   How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance [J].
Eaden, JA ;
Ward, BA ;
Mayberry, JF .
GASTROINTESTINAL ENDOSCOPY, 2000, 51 (02) :123-128
[5]   Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease [J].
Eaden, JA ;
Mayberry, JF .
GUT, 2002, 51 :V10-V12
[6]   The risk of colorectal cancer in ulcerative colitis: a meta-analysis [J].
Eaden, JA ;
Abrams, KR ;
Mayberry, JF .
GUT, 2001, 48 (04) :526-535
[7]   INCREASED RISK OF LARGE-BOWEL CANCER IN CROHNS-DISEASE WITH COLONIC INVOLVEMENT [J].
EKBOM, A ;
HELMICK, C ;
ZACK, M ;
ADAMI, HO .
LANCET, 1990, 336 (8711) :357-359
[8]   ULCERATIVE-COLITIS AND COLORECTAL-CANCER - A POPULATION-BASED STUDY [J].
EKBOM, A ;
HELMICK, C ;
ZACK, M ;
ADAMI, HO .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (18) :1228-1233
[9]   Surveillance for dysplasia in patients with inflammatory bowel disease: A national survey of colonoscopic practice in New Zealand [J].
Gearry, RB ;
Wakeman, CJ ;
Barclay, ML ;
Chapman, BA ;
Collett, JA ;
Burt, MJ ;
Frizelle, FA .
DISEASES OF THE COLON & RECTUM, 2004, 47 (03) :314-322
[10]   ULCERATIVE-COLITIS AND CROHNS-DISEASE - A COMPARISON OF THE COLORECTAL-CANCER RISK IN EXTENSIVE COLITIS [J].
GILLEN, CD ;
WALMSLEY, RS ;
PRIOR, P ;
ANDREWS, HA ;
ALLAN, RN .
GUT, 1994, 35 (11) :1590-1592